OC-0599 Factors associated with SBRT doses in oligometastatic disease: an EORTC/ESTRO OligoCare analysis. (May 2022)

• Record Type: Journal Article
• Authors: Guckenberger, M.; Alongi, F.; Ricardi, U.; Scorsetti, M.; Balermpas, P.; Livi, L.; Lievens, Y.; Braam, P.; Jereczek- Fossa, B.A.; Stellamans, K.; Ratosa, I.; Peulen, H.; Widder, J.; Ramella, S.; Verbeke, L.; Dirix, P.; Khanfir, K.; Zilli, T.; Hemmatazad, H.; Jeene, P.; Ivaldi, G.B.; Clementel, E.; Fournier, B.; Fortpied, C.; Ost, P.
• Is Part Of: Radiotherapy and oncology. Volume 170(2022)Supplement 1
• Page Start: S523
• Page End: S524
• Publication Date: 2022-05
• Subjects: Oncology -- Periodicals; Radiotherapy -- Periodicals; Tumors -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- radiotherapy -- Periodicals; Radiotherapy -- Periodicals; Radiothérapie -- Périodiques; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9940642
• DOI: 10.1016/S0167-8140(22)02621-4
• Languages: English
• ISSNs: 0167-8140